Systematic Review and Metanalysis of Clinical Outcomes After Enucleation of Pancreatic Metastases from Renal Cell Carcinoma (original) (raw)

Abstract

Introduction: A systematic review and meta analysis of the literature was carried out to determine the clinical and oncological outcome of patients who had enucleation of solitary pancreatic metastases from renal cell carcinoma. Methods: Operative mortality, postoperative complications, observed survival and disease free survival were analyzed. The clinical outcomes of patients who had enucleation were compared to those of 947 patients collected from the literature who had standard or atypical pancreatic resection for the same disease using propensity score matching Results: There was no postoperative mortality in the 56 patients who had enucleation of pancreatic metastases from renal cell carcinoma. In 51 patients postoperative complications could be analyzed. Ten patients (10/51=19.6%) had postoperative complications. Three patients (3/51 = 5.9%) had major complications (Clavien-Dindo III or more). Five year observed survival rates and disease free survival for patients with enucleation were 92% and 79% respectively. These results compared favourably with those obtained in patients who had standard resection and other forms of atypical resection (also using propensity score matching). Patients who had partial pancreatic resection (atypical or not) with pancreatic-jejunal anastomosis had increased rates of postoperative complications and local recurrences. Discussion/Conclusions: Enucleation of pancreatic metastases offers a valid solution in selected patients.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (66)

  1. -Sellner F. Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection? Clin Exp Metastasis. 2018 ;35: 91-102
  2. -Jaen-Torrejimeno I, Rojas-Holguín A, López-Guerra D, Ramia JM, Blanco-Fernández G. Pancreatic resection for metastatic renal cell carcinoma. A systematic review. HPB (Oxford). 2019 Oct 28. doi: 10.1016/j.hpb.2019.10.017
  3. -Anderson B, Williams GA, Sanford DE , Liu J, Dageforde LA, Hammill CW, et al A 22-year experience with pancreatic resection for metastatic renal cell carcinoma. HPB (Oxford). 2019 Jul 23 . doi: 10.1016/j.hpb.2019.05.019.
  4. -Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C et al "ICUD-EAU International Consultation on kidney cancer 2010: Treatment of metastatic disease" Eur Urology 2011; 60: 684-690
  5. -Brozzetti S, Sterpetti AV: Unexpected prolonged survival after estended and emergent resection of pancreatic metastases from renal cell carcinoma.
  6. J Gastrointest Cancer. 2019; 50: 1055-1058. doi: 10.1007/s12029-019-00209-w
  7. -Stukalin I, Alimohamed N, Heng DYC : "Contemporary treatment of metastatic renal cell carcinoma " Oncology Reviews 2016; 10:295
  8. -Santoni M, Conti A, Partelli S, Porta C, Sternberg CN, Procopio G et al "Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors" Ann Surg Oncol 2015; 22:2094-2100
  9. -Motzer RJ, Escudier B, Choueiri TK: "Treatment of advanced renal cell carcinoma " N Engl J Med 2016; 374-889- 890
  10. -Choueiri TK, Motzer RJ "Systemic therapy for metastastic renal cell carcinoma" N Engl J Med 2017; 376: 354-366
  11. -Asbun HJ, Moekotte A L. , Vissers FL, Kunzler F, Cipriani F, Alseidi A et al The Miami International evidence- based guidelines on minimally invasive pancreas resection. Ann Surgery.2020; 271:1-14
  12. -Girgis, MD, Zenati, M S, King JC, Hamad A, Zureikat AH, Zeh HJ, et al Oncologic outcomes after robotic pancreatic resections are not inferior to open surgery. Ann Surg 2021; e262-e268 doi 10.1097/SLA.0000000000003615
  13. -Dindo D, Demartines M, Clavien PA: "Classification of surgical complications" Ann Surg 2004; 240: 205-213
  14. -Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M et al International Study Group on Pancreatic Surgery (ISGPS). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years Aft Surgery. 2017 ;161:584-591. doi: 10.1016/j.surg.2016.11.014.
  15. -Sterpetti AV, Costi U, D'Ermo G. National statistics about resection of the primary tumor in asymptomatic patients with Stage IV colorectal cancer and unresectable metastases. Need for improvement in data collection. A systematic review with meta-analysis. Surg Oncol. 2019 ;33:11-18. doi: 10.1016/j.suronc.2019.12.004.
  16. -Sauvanet A, Barthes T, Levy P, Flejou JF, Delcenserie R, Bernades P et al Late pancreatic metastasis from renal cell carcinoma. Pancreas. 1993 ;8: 742-4.
  17. -Hashimoto M, Watanabe G, Matsuda M, Dohi T, Tsurumaru M Management of pancreatic metastases from renal cell carcinoma: report of four resected cases. Hepatogastroenterology 1998: 45:1150-1154
  18. -Kassabian A, , Stein J, Jabbour N, Parsa K, Skinner D, Parekh D et al Renal cell carcinoma metastatic to the pancreas. A single-institution series and review of the literature UROLOGY 2000; 56: 211-215
  19. -Uemura T, Kurita A, Nishimura R, Ishizaki M Solitary pancreatic metastasis from renal cell carcinoma concomitant with early gastric cancer 17 years after nephrectomy: report of a case. Surg Today. 2003;33: 395-398.
  20. -Bassi C, Butturini G, Falconi M, Sargenti M, Mantovani W, Pederzoli et al High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg. 2003 ;90(5):555-559
  21. -Nakagohri T1, Konishi M, Inoue K Partial pancreatic head resection for pancreatic metastasis from renal cell carcinoma. Hepatogastroenterology. 2003; 50:2236-2238
  22. -Köhler K, Haroske G, Ludwig K Management of pancreatic metastases Zentralbl Chir. 2006 ;131:425-428
  23. -Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V et al Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol. 2008; 15 :1161-1168. doi: 10.1245/s10434-007-9782-0
  24. -Volk A, Kersting S, Konopke R, Dobrowolski F, Franzen S, Ockert D et al Surgical therapy of intrapancreatic metastasis from renal cell carcinoma. Pancreatology. 2009;9: 392-397. doi: 10.1159/000181174.
  25. -Akashi Y, Saiura A, Kishi Y , Koga R, Morimura R, Yoshioka R et al Outcome after surgical resection of isolated metastases to the pancreas. Hepatogastroenterology. 2010;57: 1549-1552.
  26. -Gardini A, Morgagni P, Milandri C, Riccobon A, Ridolfi R, La Barba G et al Pancreatic resection for metastases from renal cancer: long term outcome after surgery and immunotherapy approach -single center experience. Hepatogastroenterology. 2012;59: 687-690. doi: 10.5754/hge12185
  27. -Konstantinidis IT, Dursun A, Zheng H, Wargo JA, Thayer SP, Fernandez-del Castillo C et al Metastatic tumors in the pancreas in the modern era. J Am Coll Surg. 2010 ;211:749-53. doi: 10.1016/j.jamcollsurg.2010.08.017.
  28. -Chirletti P, Peparini N, Caronna R Wedge Resection of the Pancreatic Head for Metastatic Renal Cell Carcinoma: Midway between Enucleation and Inferior Head Resection. Am Surgeon 2011; 77: E 30-E32
  29. -You DD, Choi DW, Choi SH, Heo JS, Kim WS, Ho CY et al Surgical resection of metastasis to the pancreas. J Korean Surg Soc. 2011;80: 278-282. doi: 10.4174/jkss.2011.80.4.278.
  30. -Yazbek T, Gayet B. The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma. JOP. 2012 ;13: 433-438.
  31. -Yuasa T, Inoshita N, Saiura A, Yamamoto S, Urakami S, Masuda H et al Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer. 2015 ;15:46. doi: 10.1186/s12885-015-1050-2.
  32. -Kusnierz K, Mrowiec S, Lampe P. Results of surgical management of renal cell carcinoma metastatic to the pancreas. Contemp Oncol (Pozn). 2015;19: 54-59. doi: 10.5114/wo.2014.45306
  33. -Wu C, Zhou Z, Ye X Synchronous renal cell carcinoma metastasis to the contralateral adrenal gland and pancreas: A case report with 7-year follow-up subsequent to surgical therapy. Oncol Lett. 2016 Jun;11(6):4144-4146.
  34. -Boni A, Cochetti G, Ascani S Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature. BMC Surg. 2018;18(1):40. doi: 10.1186/s12893-018-0371-x.
  35. -Schwarz L, Sauvanet A, Regenet N, Mabrut JY, Gigot JF, Housseau E et al Long term survival after pancreatic resection for renal cell carcinoma metastasis . Ann Surg Oncol 2014; 21:4007-4013
  36. -Untch BR, Allen BR : "Pancreatic metastasectomy: The Memorial Sloan-Kettering experience and review of the literature" J Surg Oncol 2014; 109: 28-30
  37. -Benhaim R, Oussoultzoglou E, Saeedi Y, Mouracade P, Bachellier P, Lang H Pancreatic metastasis from renal cell carcinoma: Outcome of an aggressive approach" Urology 2015; 85: 135-140
  38. -Ruckert F, Distler M, Ollmann D, Lietzmann A, Birgin E, Teoule P et al Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases. Int J Surg. 2016 Feb;26:64-8. doi: 10.1016/j.ijsu.2015.12.003.
  39. -Motoyama S, Terashima H, Matsuoka T A case of renal cell carcinoma metastasizing to pancreas aqnd skin 19 years after nephrectomy. Jpn J Gastroenterol Surg 1993; 26: 2859-2863
  40. -Ishikawa T, Horimi T, Majima K: A resescted case of pancreatic tumor metastasized from renal cell carcinoma. A review of 11 cases in the Japanese and 13 cases of the foreign literature. J Jpn Soc Clin Surg 1993; 54: 1642- 1647
  41. -Sperti C, Pasquali C, Liessi G, Pinciroli L, Decet G, Pedrazzoli S. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol. 2003 Jul;83(3):161-6; discussion 166. Review.
  42. -Deguchi Y, Shimada K, Nara S Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case. Surg Today. 2009;39(12):1086-90. doi: 10.1007/s00595-008-3998-x.
  43. -Strobel O, Hackert T, Hartwig W, Bergmann F, Hinz U, Wente MN et al Survival data justifies resection for pancreatic metastases. Ann Surg Oncol. 2009 Dec;16(12):3340-9. doi: 10.1245/s10434-009-0682-3.
  44. -Kitasato A, Tajima Y, Kuroki T, Tsutsumi R, Tsuneoka N, Adachi T et al Limited pancreatectomy for metastatic pancreatic tumors from renal cell carcinoma. Hepatogastroenterology. 2010 Mar-Apr;57(98):354-7.
  45. -Wiltberger G, Bucher JN, Krenzien F, Benzing C, Atanasov G, Schmelzle M et al Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis. BMC Surg. 2015 Dec 11;15:126. doi: 10.1186/s12893-015-0114-1.
  46. -Assouad J, Banu E, Brian E, Pham DN, Dujon A, Foucault C et al Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
  47. Eur J Cardiothorac Surg. 2008 May;33(5):794-8. doi: 10.1016/j.ejcts.2008.01.045.
  48. -.Yoshikawa Y1, Murakami M, Shimizu J A case of partial pancreatectomy for recurrent metastatic renal cell carcinoma in the remnant pancreas after subtotal stomach-preserving pancreaticoduodenectomy. Gan To Kagaku Ryoho. 2013 Nov;40(12):1900-2.
  49. -Macrì A, Fleres F, Putortì A, Lentini M, Ascenti G, Mastrojeni C. Relapsed metachronous pancreatic metastasis from renal cell carcinoma (RCC): report of a case and review of literature. Ann Ital Chir. 2014;85(ePub). pii: S2239253X1402
  50. -Ishikawa H, Sakata J, Soma D. Repeated Pancreatic Resections with Parenchymal Preservation for Pancreatic Metastases of Renal Cell Carcinoma--Report of a Case]. Gan To Kagaku Ryoho. 2015 Nov;42(12):2254- 5.
  51. -Surveillance, Epidemiology and End Results Program: SEER fast stats: compare statistics by cancer site. Kidney and renal pelvis: 1975-2013. Bethesda-MD: National Cancer Institute 2016;
  52. -Tosoian JJ, Cameron JL, Allaf ME, Hruban RH, Nahime CB, Pawlik TM et al: "Resection of isolated renal cell carcinoma metastases to the pancreas. Outcomes from the John Hopkins Hospital" J Gastrointest Surg 2014; 18: 542-548
  53. -Heng DYC, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C et al "Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study" J Clin Oncol 2009; 34: 5794-5799
  54. -Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL et al "Survival analyses of patients with metastatic renal cell carcinoma treated with targeted therapy with or without cyto reductive nephrectomy: a National cancer data base study" J Clin Oncol 2016; 34: 3267-3275
  55. -Gravis G, Chanez B, Derosa L, Beuselinck B, Barthelemy P, Laguerre B, et al "Effect of glandular metastases on overall survival in patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era ". Urol Oncol 2016; 34; 167: e17-23
  56. -Karimi K, McFadden DW: Pancreatic resection for metastastic renal cell carcinoma to the pancreas. Am Surgeon 2007; 73: 1158-1160
  57. -Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB (Oxford). 2009 Mar;11(2):150-3. doi: 10.1111/j.1477-2574.2009.00027.x.
  58. -Rini BI, Atkins MB: "Resistance to targeted therapy in renal cell carcinoma" Lancet Oncol 2009; 10: 992-1000
  59. -Lee CH, Motzer RJ "Immune checkpoint therapy in renal cell carcinoma" Cancer J 2016; 22;92-95
  60. -Borrelli V, Sterpetti AV, Coluccia P, Randone B, Cavallaro A, Santoro D'Angelo L et al Bimodal concentration- dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture.J Surg Res. 2001 Oct;100(2):154-60. doi: 10.1006/jsre.2001.6231.PMID: 11592785
  61. -Chua TC, Yang TX, Gill AJ, Samra GS Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions. Ann Surg Oncol. 2016 ; 23: 592-599.
  62. -Strobel O, Cherrez A, Hinz U, Mayer P, Kaiser J, Fritz S, et al Risk of pancreatic fistula after enucleation of pancreatic tumours. Br J Surg. 2015;102: 1258-1266
  63. -Sterpetti AV, Sapienza P. Adenocarcinoma in the transposed colon: High grade active inflammation versus low grade chronic inflammation.
  64. Eur J Surg Oncol. 2019 Sep;45(9):1536-1541. doi: 10.1016/j.ejso.2019.05.012.
  65. -Sterpetti AV, Marzo LD, Sapienza P. Risk factors for adenocarcinoma in the surgically transposed colon not exposed to the fecal stream. Etiological considerations extrapolated to sporadic colon carcinoma in the general population. Eur J Surg Oncol. 2021 May;47(5):931-934. doi: 10.1016/j.ejso.2020.10.026.
  66. --Cucina A, Borrelli V, Di Carlo A, Pagliei S, Corvino V, Santoro-D'Angelo L et al Thrombin induces production of growth factors from aortic smooth muscle cells. J Surg Res. 1999 Mar;82(1):61-6. doi: 10.1006/jsre.1998.5514.PMID: 10068527